Chemo-Pharma Laboratories Board of Directors
Get the latest insights into the leadership at Chemo-Pharma Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Bhavin Sheth | Executive Director & CEO |
| Mr. Ashok Somani | Executive Director & CFO |
| Mrs. Shanta Somani | Non Executive Director |
| Mr. Mathura Prasad Sharma | Independent Director |
| Mr. Toby Antony | Independent Director |
| Mr. Nandkumar Pareek | Independent Director |
Chemo-Pharma Laboratories Share price
CHEMOPH
121.05
4.75 (-3.78%)Last updated on 4 Sep, 2025 | 10:50 IST
BUYSELL
Today's High
129.40
Today's Low
120.55
52 Week Low
59.58
52 Week High
154.00
The current prices are delayed, login to your account for live prices
LoginChemo-Pharma Laboratories FAQs
The board at Chemo-Pharma Laboratories consists of experienced professionals, including Mr. Bhavin Sheth , Mr. Ashok Somani , and others, overseeing the company’s strategic and corporate governance.
Directors at Chemo-Pharma Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Bhavin Sheth is the current chairman at Chemo-Pharma Laboratories.
Executive directors at Chemo-Pharma Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Chemo-Pharma Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Chemo-Pharma Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.